Infertility

Emerging information on the link between ovarian cancer and endometriosis gives us an unprecedented opportunity to develop comprehensive screening plans for early detection and prevention of specific types of ovarian cancer.

Like many of my patients, my life revolves around information. Personally, I use the same technology as most of you to keep track of obligations and loved ones. Professionally, the Houston Fertility Center team uses technology and constant communication to manage our patients' treatment plans. In this era of digital info, we can all feel more empowered, more often, more quickly. It seems like there's always room for more information, doesn't it?

IVF has made great strides in assisting women with infertility problems. However, many women believe that achieving pregnancy in their 40s is as simple as going to a fertility clinic.

Here's a situation that illustrates how fantastic medical advances don't always translate to patients benefiting in the clinic. For that to happen, the science needs to be carried along a pipeline of practitioner communication, all the way to the patient.

I know what you're thinking: How can an issue like infertility teach us about customizing healthcare? And how can the assisted reproduction field help raise standards in women's healthcare? But it can, and it does… or it should.

Ovarian hyperstimulation syndrome (OHSS) appears in 3% to 8% of in vitro fertilization cycles. Now, new research shows that cabergoline, a dopamine agonist, can be effective in preventing OHSS in this patient population.

Women over the age of 50 who achieve a viable pregnancy via donor-egg in vitro fertilization (D-IVF) have no greater incidence of adverse outcomes than younger women,according to a new study published in the American Journal of Perinatology.

Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.

Your patient just received devastating news: she has cancer. As treatment options and anxieties swirl, more and more women are now faced with another issue: how will the cancer and its treatment impact their fertility?

Orthodox Jewish women may follow an ancient tradition that requires sexual abstention during her menses and for the seven days that follow. Once the woman has completed the period of sexual abstention she immerses in a ritual bath to purify her soul and then is encouraged to have intercourse with her husband but when your patient experiences infertility, how do you treat the infertility while maintaining respect for her religious traditions?

Two new studies published in the New England Journal of Medicine point to the importance of using bevacizumab in the treatment of ovarian cancer. Bevacizumab, a recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor, has shown single-agent activity in women with recurrent tumors.

Endometriosis affects as many as 6% of the general population. While some women with endometriosis remain asymptomatic, many women experience dysmenorrhea, dyspareunia, non-cyclical pelvic pain, and subfertility. Now, new research indicates that patients with endometriosis are also more likely to develop inflammatory bowel disease.

As infertility rates have increased, now affecting as many as 12% of the reproductive age population, so has the use of assisted conception. For instance, in vitro fertilization was employed in about 1% of all live births in the United States.

Lead researcher Dr Janet McLaren discusses the results of a new study exploring new concerns that rheumatoid arthritis, lupus, and inflammatory bowel disease may lead to premature ovarian failure and early menopause.

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 19th Annual Meeting of ESHRE - Madrid, Spain

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference Coveragefrom the 18th Annual Meeting of ESHRE - Vienna, Austria

OBGYN.net Conference CoverageFrom the ESHRE 2001 Conference - Lausanne, Switzerland